Company intelligence / Profile preview

DNA Communications

New York City, New York, United States

Ownership: Private
Employees: ~87
Development stage: Other

Overview

DNA Communications is a leading healthcare communications agency specializing in translating complex scientific concepts into accessible and engaging messages for the life sciences industry, with significant growth and established presence in North America and Europe. The agency does not conduct drug development but supports biopharma communication at all stages. It is part of The Weber Shandwick Collective within Interpublic Group.

Industry: Consulting

Partnerships

PfizerNS Pharma4DMTBoehringer IngelheimIovance

Beyond the preview

Go deeper on DNA Communications.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA Communications.

Explore the full profile